Use this URL to cite or link to this record in EThOS:
Title: Investigation of antibiotic targets in the decaprenyl-phosphorylarabinose biosynthesis in M. tuberculosis
Author: Tóth, Szilvia
ISNI:       0000 0004 7967 9983
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Access from Institution:
An estimated 1.67 million people died of tuberculosis (TB) in 2016 and it is a threat to human life on a global-scale. To shorten current treatments and battle drug resistant strains it is important to discover and develop new drugs against the causative agent, Mycobacterium tuberculosis. Phenotypic screens have delivered potent hit molecules in the past but the need to target new pathways in M. tuberculosis metabolism to circumvent pre-existing drug resistance mechanisms is necessary. The decaprenyl-phosphorylarabinose (DPA) biosynthetic pathway, especially the enzyme DprE1 has received much attention, however DprE2 has been overlooked as a potential drug target. In this thesis the role of a small region of DprE1 in ligand binding and physiological function has been investigated. This region appears to interact with the substrate and based on enzyme activity assays, physiological importance of specific residues was found to be in line with the level of conservation between species. In addition, a high-throughput screen against a DprE2 overexpressing M. bovis BCG strain has been utilised to discover new hit compounds. The screen resulted nitrofuran hit compounds that probably act as prodrugs, which was indicated by spontaneous resistant mutants resembling the mutations necessary to activate new TB pro-drug pretomanid.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: QR Microbiology